LIMITED OFFER
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code needed.
Side Effects of Drugs Annual
A worldwide yearly survey of new data in adverse drug reactions
- 1st Edition, Volume 35 - March 4, 2014
- Editor: Jeffrey K Aronson
- Language: English
- Hardback ISBN:9 7 8 - 0 - 4 4 4 - 6 2 6 3 5 - 6
- eBook ISBN:9 7 8 - 0 - 4 4 4 - 6 2 6 3 6 - 3
The Side Effects of Drugs Annual was first published in 1977. It has been continually published since then as a yearly update to the voluminous encyclopedia, Meyler's Side Effects… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteThe Side Effects of Drugs Annual was first published in 1977. It has been continually published since then as a yearly update to the voluminous encyclopedia, Meyler's Side Effects of Drugs. Each new Annual continues to provide clinicians and medical investigators with a reliable and critical yearly survey of new data and trends in the area of adverse drug reactions and interactions. An international team of specialists has contributed to the informative Annual by critically interpreting it and by pointing to whatever is misleading.
- Provides a critical yearly survey of new data and trends
- Special reviews in this Annual include, among other topics, epidemiology of the use of ecstasy, paracetamol and the risk of asthma, combination vaccines/multiple immunizations, interactions of herbal medicines with warfarin, and tyrosine kinase inhibitors
Pharmacologists, clinicians, pharmaceutical companies, clinical toxicologists, clinical pharmacologists and medical libraries
Contributors
Special reviews in SEDA-35
Cumulative indexes of special reviews, Annuals 4–34
1 Index of medications in special reviews
2 Index of adverse effects and adverse reactions in special reviews
Table of Essays, Annuals 1–34
Mechanistic and clinical descriptions of adverse drug reactions
1 EIDOS
2 DoTS
Definitive (between-the-eyes) adverse drug reactions
How to use this book
The scope of the Side Effects of Drugs Annuals
Period covered
Selection of material
Allocation of drugs to chapters
Names of drugs and chemicals
System of tagging references
Indexes
Abbreviations
35 years of the Side Effects of Drugs Annuals—a tribute to our contributors
Classification of immunological reactions
Classification of drug teratogenicity
Grades of adverse drug reactions
Side effects of drugs essay
Abstract
Chapter 1: Central nervous system stimulants and drugs that suppress appetite
Abstract
Amphetamines [SED-15, 180; SEDA-32, 1; SEDA-33, 1; SEDA-34, 1]
Methylxanthines
Drugs That Suppress Appetite [SEDA-32, 16; SEDA-33, 13; SEDA-34, 8]
Drugs Used in Alzheimer’s Disease [SEDA-32, 19; SEDA-33, 15; SEDA-34, 9]
Chapter 2: Antidepressant drugs
Abstract
General
Selective Serotonin Re-uptake Inhibitors (SSRIs) [SED-15, 3109; SEDA-32, 33; SEDA-33, 26; SEDA-34, 37]
Serotonin and Noradrenaline Re-uptake Inhibitors (SNRIs)
Tricyclic Antidepressants
Monoamine Oxidase Inhibitors
Other Antidepressants
Chapter 3: Lithium
Abstract
Chapter 4: Drugs of abuse
Abstract
Cannabinoids [SED-15, 614; SEDA-32, 55; SEDA-33, 55; SEDA-34, 33]
Opioid Analgesics
Chapter 5: Hypnosedatives and anxiolytics
Abstract
Azaspirones [SEDA-32, 75; SEDA-33, 71; SEDA-34, 45]
Benzodiazepines [SED-15, 429; SEDA-32, 75; SEDA-33, 45]
Benzodiazepine-Like Drugs
Benzodiazepine Antagonists
Other Hypnosedatives
Chapter 6: Antipsychotic drugs
Abstract
General [SED-15, 2438; SEDA-32, 83; SEDA-33, 89; SEDA-34, 51]
Individual Drugs
Chapter 7: Antiepileptic drugs
Abstract
Chapter 8: Opioid analgesics and narcotic antagonists
Abstract
General
Opioid Receptor Agonists
Partial Opioid Receptor Agonists
Opioid Receptor Antagonists
Chapter 9: Anti-inflammatory and antipyretic analgesics and drugs used in gout
Abstract
Amidopyrine and Related Compounds
Aniline Derivatives [SED-15, 2679; SEDA-33, 244; SEDA-34, 184]
Non-steroidal Anti-inflammatory Drugs
Anthranilic Acid Derivatives
Arylalkanoic Acid Derivatives [SED-15, 2555; SEDA-32, 229; SEDA-33, 245; SEDA-34, 185]
COX-2 Selective Inhibitors [SEDA-32, 232; SEDA-33, 246; SEDA-34, 186]
Oxicams [SEDA-15, 2555; SEDA-32, 233; SEDA-33, 247; SEDA-34, 187]
Pyrazolone Derivatives (Phenylbutazone and Related Compounds) [SEDA-27, 111]
Salicylates [SED-15, 15; SEDA-33, 248; SEDA-34, 188]
Miscellaneous Drugs
Drugs Used in the Treatment of Gout
Chapter 10: General anesthetics and therapeutic gases
Abstract
Anesthetic Vapors [SEDA-32, 243; SEDA-33, 257; SEDA-34, 195]
Other Vapors
Intravenous Agents: Non-barbiturate Anesthetics
Intravenous Agents: Barbiturate Anesthetics
Chapter 11: Local anesthetics
Abstract
General
Effects Related to Modes of Use [SED-15, 2121; SEDA-32, 262; SEDA-33, 281; SEDA-34, 209]
Caudal, Epidural, and Spinal Anesthesia
Individual Compounds
Chapter 12: Neuromuscular blocking agents and skeletal muscle relaxants
Abstract
Depolarizing Neuromuscular Blocking Agents
Non-depolarizing Neuromuscular Blocking Agents [SED-15, 2489; SEDA-32, 274; SEDA-33, 301; SEDA-34, 222]
Skeletal Muscle Relaxants
Chapter 13: Drugs that affect autonomic functions or the extrapyramidal system
Abstract
Drugs That Stimulate Both Alpha- and Beta-Adrenoceptors [SEDA-32, 281; SEDA-33, 313; SEDA-34, 233]
Drugs That Predominantly Stimulate Alpha1-Adrenoceptors [SEDA-32, 283; SEDA-33, 318; SEDA-34, 236]
Drugs That Stimulate Beta1-Adrenoceptors [SEDA-32, 284; SEDA-33, 265; SEDA-34, 240]
Drugs That Stimulate Beta2-Adrenoceptors [SEDA-34, 241]
Drugs That Stimulate Dopamine Receptors [SEDA-33, 266; SEDA-34, 342]
Drugs That Stimulate Dopamine Receptors
Other Drugs That Increase Dopamine Activity
Drugs That Affect the Cholinergic System [SEDA-32, 290; SEDA-33, 324; SEDA-34, 246]
Chapter 14: Dermatological drugs, topical agents, and cosmetics
Abstract
Cosmetics
Dermal Fillers
Dyestuffs [SEDA-15, 1573; SEDA-32, 296]
Fragrances
Glucocorticoids, Topical
Phototherapy and Photochemotherapy [SED-15, 2823; SEDA-32, 297; SEDA-34, 262]
Sunscreens [SED-15, 3248; SEDA-34, 263]
Vitamin A (Retinoids) [SED-15, 3653; SEDA-32, 298; SEDA-34, 264; for vitamin A carotenoids see Chapter 34]
Vitamin D Analogues, Topical [SED-15, 594; SEDA-32, 301; SEDA-34, 265; for oral Vitamin D analogues see Chapter 34]
Devices
Chapter 15: Antihistamines (H1 receptor antagonists)
Abstract
General
Other Antihistamines
Chapter 16: Drugs that act on the respiratory tract
Abstract
Inhaled Glucocorticoids [SEDA -32, 311; SEDA -33, 353; SEDA -34, 277]
Nasal Glucocorticoids [SEDA -34, 279]
Beta2-Adrenoceptor Agonists [SEDA -32, 314; SEDA -33, 357; SEDA -34, 280]
Anticholinergic Drugs [SEDA -32, 318; SEDA -33, 363; SEDA -34, 282]
Leukotriene Modifiers [SEDA -32, 319; SEDA -33, 366; SEDA -34, 283]
Phosphodiesterase Type IV Inhibitors [SEDA -32, 321; SEDA -33, 367; SEDA -34, 284]
Mucolytic Drugs [SEDA -32, 325; SEDA -33, 369]
Antitussive Drugs
Chapter 17: Positive inotropic drugs and drugs used in dysrhythmias
Abstract
Cardiac Glycosides [SED-15, 648; SEDA-32, 333; SEDA-33, 377; SEDA-34, 287]
Other Positive Inotropic Drugs [SED-15, 2822; SEDA-31, 323; SEDA-32, 336; SEDA-33, 378]
Antidysrhythmic Drugs
Adenosine Receptor Agonists [SEDA-32, 337; SEDA-33, 379; SEDA-34, 292]
Chapter 18: Beta-adrenoceptor antagonists and antianginal drugs
Abstract
Beta-Adrenoceptor Antagonists [SED-15, 452; SEDA-32, 363; SEDA-33, 397; SEDA-34, 303]
Potassium Channel Activators
Nitrates, Organic [SED-15, 2529; SEDA-32, 366; SEDA-33, 400; SEDA-34, 305]
Calcium Channel Blockers [SED-15, 598; SEDA-32, 366; SEDA-33, 401; SEDA-34, 306]
Chapter 19: Drugs acting on the cerebral and peripheral circulations
Abstract
Drugs Used in the Treatment of Arterial Disorders of the Brain and Limbs
Drugs Used in the Treatment of Venous Disorders
Drugs Used in the Treatment of Migraine
Other Peripheral Vasodilators
Chapter 20: Antihypertensive drugs
Abstract
General
Angiotensin Converting Enzyme (ACE) Inhibitors [SED-15, 226; SEDA -32, 379; SEDA -33, 416; SEDA-34, 321]
Angiotensin II Receptor Antagonists [SED-15, 223; SEDA-32, 387; SEDA-33, 418; SEDA-34, 325]
Dual Angiotensin II Receptor Antagonists/Neprilysin Antagonists
Direct Renin Inhibitors [SEDA-32, 388; SEDA-33, 420; SEDA-34, 328]
Endothelin Receptor Antagonists [SED-15, 1215; SEDA-32, 389; SEDA-33, 421; SEDA-34, 328]
Drugs That Act on the Sympathetic Nervous System [SEDA-32, 391; SEDA-33, 424; SEDA-34, 329]
Non-selective α-Adrenoceptor Antagonists
Postsynaptic α-Adrenoceptor Antagonists [SEDA-32, 391; SEDA-33, 425; SEDA-34, 330]
Imidazoline Receptor Agonists
Direct Vasodilators
Chapter 21: Diuretics
Abstract
Carbonic Anhydrase Inhibitors [SED-15, 643; SEDA-32, 403; SEDA-33, 437; SEDA-34, 339]
Thiazide and Thiazide-Like Diuretics [SED-15, 3375; SEDA-32, 405; SEDA-33, 438; SEDA-34, 340]
Loop Diuretics [SED-15, 567, 1454; SEDA-32, 408; SEDA-33, 440; SEDA-34, 342]
Aldosterone Receptor Antagonists
Osmotic Diuretics
Chapter 22: Metals
Abstract
Chapter 23: Metal antagonists
Abstract
Iron Chelators
Penicillamine and Related Drugs [SED-15, 2729; SEDA-32, 430; SEDA-33, 472; SEDA-34, 372]
Other Chelators
Polystyrene Sulfonates [SED-15, 2894; SEDA-32, 433; SEDA-33, 474; SEDA-34, 373]
Chapter 24: Antiseptic drugs and disinfectants
Abstract
Aldehydes [SED-15, 1439, 1513; SEDA-32, 437; SEDA-33, 479; SEDA-34, 377]
Bisbiguanides
Boric Acid
Cationic Surfactants
Halogens
Iodophors [SED-15, 1896; SEDA-32, 440; SEDA-33, 485; SEDA-34, 380]
Phenols [SED-15, 2800, SEDA-32, 441; SEDA-33, 485; SEDA-34, 381]
Chapter 25: Penicillins, cephalosporins, other beta-lactam antibiotics, and tetracyclines
Abstract
Beta-Lactam Antibiotics [SED-15, 478; SEDA-32, 447; SEDA-33, 491; SEDA-34, 385]
Cephalosporins [SED-15, 688; SEDA-32, 448; SEDA-33, 493; SEDA-34, 386]
Monobactams and Monocarbams [SED-15, 2378; SEDA-32, 450; SEDA-33, 494; SEDA-34, 388]
Penicillins [SED-15, 2756; SEDA-32, 450; SEDA-33, 495; SEDA-34, 388]
Tetracyclines and Glycylcyclines [SED-15, 3330; SEDA-32, 451; SEDA-33, 497; SEDA-34, 391]
Chapter 26: Miscellaneous antibacterial drugs
Abstract
Aminoglycosides [SED-15, 118; SEDA-32, 461; SEDA-33, 509; SEDA-34, 399]
Fluoroquinolones [SED-15, 1396; SEDA-32, 464; SEDA-33, 514; SEDA-34, 401]
Glycopeptides [SEDA-32, 469; SEDA-33, 519; SEDA-34, 405]
Ketolides [SED-15, 1976; SEDA-32, 471; SEDA-33, 521; SEDA-34, 407]
Lincosamides [SED-15, 2063; SEDA-32, 472; SEDA-33, 522; SEDA-34, 407]
Macrolides [SED-15, 2183; SEDA-32, 472; SEDA-33, 522; SEDA-34, 408]
Nitrofurantoin [SED-15, 2542; SEDA-32, 476, SEDA-33, 525; SEDA-34, 409]
Oxazolidinones [SED-15, 2645; SEDA-32, 474; SEDA-33, 525; SEDA-34, 409]
Polymyxins [SED-15, 2891; SEDA-32, 476; SEDA-33, 527; SEDA-34, 412]
Streptogramins [SED-15, 3182; SEDA-32, 528; SEDA-34, 413]
Sulfonamides, Trimethoprim, and Co-trimoxazole [SED-15, 3216, 3510; SEDA-32, 477; SEDA-33, 528; SEDA-34, 414]
Other Antimicrobial Drugs
Chapter 27: Antifungal drugs
Abstract
Allylamines [SEDA -32, 491; SEDA -33, 541; SEDA -34, 427]
Amphotericin [SED -15, 192; SEDA -32, 493; SEDA -33, 542; SEDA -34, 427]
Antifungal Azoles [SED -15, 301; SEDA -32, 497; SEDA -33, 545; SEDA -34, 428]
Echinocandins [SED -15, 1197; SEDA -32, 507; SEDA -33, 556; SEDA -34, 434]
Chapter 28: Antiprotozoal drugs
Abstract
Antimalarial Drugs
4-Aminoquinolines (Chloroquine and Congeners) [SEDA-32, 521; SEDA-33, 567; SEDA-34, 441]
Pyrimethamine and Combinations [SED-15, 2984; SEDA-32, 523; SEDA-33, 570]
Primaquine and Congeners [SED-15, 2919; SEDA-33, 569; SEDA-34, 442]
Quinine and Congeners [SED-15, 3002; SEDA-32, 524; SEDA-33, 570]
Endoperoxides [SED-15, 342; SEDA-32, 525; SEDA-33, 571; SEDA-34, 442]
Drugs Used in the Treatment of Other Protozoal Infections
Chapter 29: Antiviral drugs
Abstract
Drugs Active Against Cytomegalovirus
Drugs Active Against Herpesviruses [SEDA-32, 530; SEDA-33, 577; SEDA-34, 450]
Drugs Active Against Hepatitis Viruses
Direct-Acting Antiviral Protease Inhibitors
Drugs Active Against Human Immunodeficiency Virus: Combinations
Drugs Active Against Human Immunodeficiency Virus: Nucleoside Analogue Reverse Transcriptase Inhibitors (NRTI) [SED-15, 2586; SEDA-32, 534; SEDA-33, 585; SEDA-34, 456]
Drugs Active Against Human Immunodeficiency Virus: Nucleotide Analogue Reverse Transcriptase Inhibitors
Drugs Active Against Human Immunodeficiency Virus: Non-nucleoside Reverse Transcriptase Inhibitors (NNRTI) [SED-15, 2553; SEDA-32, 537; SEDA-33, 590; SEDA-34, 459]
Drugs Active Against Human Immunodeficiency Virus: Protease Inhibitors [SED-15, 2586; SEDA-32, 541; SEDA-33, 593; SEDA-34, 461]
Drugs Active Against Human Immunodeficiency Virus: Inhibitors of HIV Fusion [SEDA-33; 598; SEDA-34, 464]
Drugs Active Against Human Immunodeficiency Virus: Integrase Inhibitors [SEDA-33, 599; SEDA-34, 465]
Drugs Active Against Human Immunodeficiency Virus: Chemokine Receptor CCR5 Antagonists [SEDA-33, 600; SEDA-34, 465]
Drugs Active Against Influenza Viruses: Neuraminidase Inhibitors [SED-15, 2436; SEDA-32, 544; SEDA-33, 601; SEDA-34, 466]
Drugs Active Against Influenza Viruses: Ion Channel Inhibitors [SED-15, 105, 3051; SEDA-32, 544; SEDA-33, 269, 602; SEDA-34, 467]
Other Drugs
Chapter 30: Drugs used in tuberculosis and leprosy
Abstract
Rifamycins [SED-15, 3040; SEDA-32, 563; SEDA-33, 637; SEDA-34, 484]
Chapter 31: Antihelminthic drugs
Abstract
Benzimidazoles [SED -15, 424; SEDA -32, 572; SEDA -33, 647; SEDA -34, 487]
Chapter 32: Vaccines
Abstract
General
Bacterial Vaccines
Viral Vaccines
Measles, Mumps, and Rubella Vaccines
Other Components of Vaccines
Chapter 33: Blood, blood components, plasma, and plasma products
Abstract
Albumin and Derivatives [SED-15, 54; SEDA-32, 591; SEDA-33, 670; SEDA-34, 509]
Blood Transfusion [SED-15, 529; SEDA-32, 593; SEDA-33, 671; SEDA-34, 509]
Blood Substitutes [SEDA-32, 593; SEDA-33, 672; SEDA-34, 511]
Plasma and Plasma Products [SED-15, 2847; SEDA-32, 594; SEDA-33, 674; SEDA-34, 512]
Plasma Substitutes [SEDA-32, 594; SEDA-33, 675; SEDA-34, 513]
Globulins
Coagulation Proteins [SED-15, 845; SEDA-32, 596; SEDA-33, 679; SEDA-34, 518]
Erythropoietin and Derivatives [SED-15, 1243; SEDA-32, 597; SEDA-33, 681; SEDA-34, 520]
Stem Cells [SEDA-32, 599; SEDA-33, 682; SEDA-34, 522]
Chapter 34: Vitamins, amino acids, and drugs and formulations used in nutrition
Abstract
Vitamin A (Carotenoids) [SED-15, 3642; SEDA-32, 607; SEDA-33, 691; SEDA-34, 531]
Vitamins of the B Group [SED-15, 1432, 3668; SEDA-32, 608; SEDA-33, 693; SEDA-34, 531]
Vitamin C (Ascorbic Acid) [SED-15, 351; SEDA-32, 611; SEDA-33, 694; SEDA-34, 531]
Vitamin D Analogues [SED-15, 3669; SEDA-32, 612; SEDA-33, 695; SEDA-34, 532]
Vitamin E (Tocopherol) [SED-15, 3677; SEDA-32, 612; SEDA-33, 696; SEDA-34, 533]
Vitamin K Analogues [SED-15, 3681; SEDA-34, 533]
Amino Acids
Enteral and Parenteral Nutrition [SED-15, 1221, 2700; SEDA-32, 613; SEDA-33, 697; SEDA-34, 536]
Chapter 35: Drugs that affect blood coagulation, fibrinolysis, and hemostasis
Abstract
Coumarin Anticoagulants [SED-15, 983; SEDA-32, 617; SEDA-33, 707; SEDA-34, 541]
Heparins [SED-15, 1590; SEDA-32, 626; SEDA-33, 713; SEDA-34, 543]
Direct Thrombin Inhibitors [SED-15, 1142; -32, 632; SEDA-33, 717; SEDA-34, 544]
Direct Factor Xa Inhibitors [SEDA-32, 635; SEDA-34, 546]
Indirect Factor Xa Inhibitors [SEDA-32, 636; SEDA-33, 636; SEDA-34, 547]
Thrombolytic Drugs [SED-15, 3402]
Drugs that Alter Platelet Function [SEDA-32, 637; SEDA-33, 637; SEDA-34, 547]
Glycoprotein IIb-IIIa Inhibitors [SED-15, 4; SEDA-32, 638; SEDA-33, 720; SEDA-34, 548]
Thienopyridines [SED-15, 821; SEDA-32, 639; SEDA-33, 720; SEDA-34, 548]
Hemostatic Agents
Chapter 36: Gastrointestinal drugs
Abstract
Antacids [SED-15, 243; SEDA-32, 665; SEDA-33, 741; SEDA-34, 555]
Antiemetics and Drugs That Affect Gastrointestinal Motility [SEDA-32, 665; SEDA-33, 741; SEDA-34, 555]
5HT3 Receptor Antagonists [SED-15, 1365; SEDA-32, 666; SEDA-33, 744; SEDA-34, 559]
Neurokinin NK1 Receptor Antagonists [SEDA-32, 667; SEDA-33, 748; SEDA-34, 561]
Histamine H2 Receptor Antagonists [SED-15, 1629; SEDA-32, 667; SEDA-33, 748; SEDA-34, 562]
Proton Pump Inhibitors [SED-15, 2973; SEDA-32, 667; SEDA-33, 749; SEDA-34, 563]
Helicobacter Pylori Eradication Regimens [SEDA-33, 749]
Other Ulcer-Healing Agents
Cholelitholytic Agents
Laxatives and Oral Bowel Preparations [SED-15, 2008; SEDA-32, 668; SEDA-33, 753; SEDA-34, 569]
Bowel Secretagogues
Aminosalicylates [SED-15, 138; SEDA-32, 669; SEDA-33, 756; SEDA-34, 571]
Antispasmodic Agents
Antidiarrheal Agents
Probiotics
Other Gastrointestinal Agents
Chapter 37: Drugs that act on the immune system: cytokines and monoclonal antibodies
Abstract
Colony-Stimulating Factors [SEDA-32, 675; SEDA-33, 769; SEDA-34, 581]
Interferons [SED-15, 1841; SEDA-32, 676; SEDA-33, 773; SEDA-34, 581]
Interleukins [SED-15, 1831; SEDA-32, 676; SEDA-33, 777; SEDA-33, 771]
Tumor Necrosis Factor Alfa (TNF-α) and Its Antagonists [SEDA-32, 677; SEDA-33, 779; SEDA-34, 583]
VEGF Antagonists
Monoclonal Antibodies [SED-15, 2380; SEDA-32, 686; SEDA-33, 783; SEDA-34, 586]
Chapter 38: Drugs that act on the immune system: immunosuppressive and immunostimulatory drugs
Abstract
Thiopurines [SED-15, 377; SEDA-32, 717; SEDA-33, 824; SEDA-34, 633]
Immunoenhancing Drugs
Chapter 39: Corticotrophins, corticosteroids, and prostaglandins
Abstract
Corticotrophins [SED-15, 906; SEDA-32, 723; SEDA-33, 841; SEDA-34, 653]
Systemic Glucocorticoids [SED-15, 906; SEDA-32, 723; SEDA-33, 841; SEDA-34, 653]
Prostaglandins and Analogues [SED-15, 2955; SEDA-31 SEDA-32, 729; SEDA-33, 846; SEDA-34, 660]
Chapter 40: Sex hormones and related compounds, including hormonal contraceptives
Abstract
Estrogens [SED-15, 1253; SEDA-32, 736; SEDA-33, 852; SEDA-34, 663]
Hormonal Contraceptives [SED-15, 1642; SEDA-32, 741; SEDA-33, 858; SEDA-34, 667]
Antiestrogens and Selective Estrogen Receptor Modulators (SERMs) [SEDA-32, 743; SEDA-33, 859; SEDA-34, 669]
Progestogens [SED-15, 2930; SEDA-32, 747; SEDA-33, 865; SEDA-34, 671]
Progesterone Antagonists [SEDA-32, 749; SEDA-33, 866; SEDA-34, 671]
Anabolic Steroids, Androgens, and Related Compounds [SED-15, 216; SEDA-32, 751; SEDA-33, 868; SEDA-34, 672]
Antiandrogens [SEDA-32, 755; SEDA-33, 872; SEDA-34, 674]
Chapter 41: Thyroid hormones, iodine and iodides, and antithyroid drugs
Abstract
Thyroid Hormones [SED-15, 3409; SEDA-32, 763; SEDA-33, 881; SEDA-34, 679]
Iodine and Iodides [SED-15, 1896; SEDA-32, 764; SEDA-33, 883; SEDA-34, 680]
Antithyroid Drugs [SED-15, 3387; SEDA-32, 765; SEDA-33, 884; SEDA-34, 681]
Chapter 42: Insulin, other hypoglycemic drugs, and glucagon
Abstract
Glucagon [SED-15, 1510; SEDA-32, 769; SEDA-33, 889]
Insulin [SED-15, 1761; SEDA-32, 769; SEDA-33, 889; SEDA-34, 685]
Alpha Glucosidase Inhibitors [SEDA-32, 772 SEDA-33, 893]
Amylin Analogues [SEDA-32, 773; SEDA-33, 893; SEDA-34, 687]
Biguanides [SED-15, 506; SEDA-32, 773; SEDA-33, 893; SEDA-34, 687]
Dipeptidyl Peptidase 4 (DDP-4) Inhibitors [SEDA-32, 774; SEDA-33, 894; SEDA-34, 688]
Incretin Mimetics [SEDA-32, 775; SEDA-33, 896; SEDA-34, 690]
Meglitinides [SED-15, 2238; SEDA-32, 776; SEDA-33, 897; SEDA-34, 694]
Sodium–Glucose Transporter Type 2 (SGLT2) Inhibitors [SEDA-33, 898; SEDA-34, 695]
Sulfonylureas [SED-15, 3230; SEDA-32, 777; SEDA-33, 898; SEDA-34, 695]
Thiazolidinediones (Glitazones) [SED-15, 3380; SEDA-32, 779; SEDA-33, 899; SEDA-34, 696]
Peroxisome Proliferator-Activated Receptor Partial Agonists
Peroxisome Proliferator-Activated Dual Receptor Agonists [SEDA-32, 782; SEDA-33, 902; SEDA-34, 698]
Chapter 43: Corticotrophins, corticosteroids, and prostaglandins
Abstract
Vasopressin Receptor Antagonists [SEDA-34, 713]
Vasopressin and Analogues [SED-15, 3609; SEDA-32, 798; SEDA-33, 915; SEDA-34, 714]
Chapter 44: Drugs that affect lipid metabolism
Abstract
Bile Acid Sequestrants [SED -15, 1902]
Cholesteryl Ester Transfer Protein Inhibitors [SEDA -32, 817; SEDA -33, 929; SEDA -34, 723]
Fibrates [SED -15, 1358; SEDA -32, 804; SEDA -33, 922; SEDA -34,724]
HMG-CoA Reductase Inhibitors [SED -15, 1632; SEDA -32, 807; SEDA -33, 924; SEDA -34, 725]
Nicotinic Acid Derivatives [SED -15, 2512; SEDA -32, 815; SEDA -33, 928; SEDA -34, 728]
Chapter 45: Cytostatic and cytotoxic drugs
Abstract
Chapter 46: Radiological contrast agents and radiopharmaceuticals
Abstract
MRI contrast media
Ultrasound contrast agents [SED-15, 3543; SEDA-32, 855; SEDA-33, 971; SEDA-34, 758]
Radiopharmaceuticals [SED-15, 3017; SEDA-33, 973; SEDA-34, 758]
Chapter 47: Drugs used in ocular treatment
Abstract
Drugs Used in the Management of Macular Degeneration [SEDA-32, 865; SEDA-33, 977; SEDA-34, 761]
Adrenoceptor Agonists [SEDA-32, 869; SEDA-33, 982; SEDA-34, 762]
Alpha-Adrenoceptor Agonists
Antibacterial Drugs
Anticholinergic Drugs [SEDA-34, 763]
Beta-Adrenoceptor Antagonists
Carbonic Anhydrase Inhibitors
Glucocorticosteroids [SED-15, 906; SEDA-32, 871; SEDA-33, 983; SEDA-34, 764]
Non-steroidal Anti-inflammatory Drugs [SEDA-34, 764]
Prostaglandin Analogues [SEDA-32, 871; SEDA-33, 984; SEDA-34, 764]
Devices and Procedures
Chapter 48: Treatments used in complementary and alternative medicine
Abstract
Asian Herbal Medicines [SED-15, 1609; SEDA-32, 879]
Nutritional Supplements
Specific Plants
Acupuncture
Chiropractic
Moxibustion
Chapter 49: Miscellaneous drugs, materials, medical devices, and techniques
Abstract
Dyestuffs [SEDA-32, 895; SEDA-33, 1016; SEDA-34, 791]
Sclerosants [SED-15, 3107; SEDA-33, 1021; SEDA-34, 795]
Index of drugs
Index of drug-drug interactions
Index of adverse effects and adverse reactions
- No. of pages: 1056
- Language: English
- Edition: 1
- Volume: 35
- Published: March 4, 2014
- Imprint: Elsevier
- Hardback ISBN: 9780444626356
- eBook ISBN: 9780444626363
JA
Jeffrey K Aronson
Affiliations and expertise
Reader in Clinical PharmacologyRead Side Effects of Drugs Annual on ScienceDirect